Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Check-Cap Ltd. Ordinary Share

MBAINASDAQ
Healthcare
Medical - Diagnostics & Research
$1.73
$0.08(4.85%)
U.S. Market opens in 13h 12m

Check-Cap Ltd. Ordinary Share Fundamental Analysis

Check-Cap Ltd. Ordinary Share (MBAI) shows weak financial fundamentals with a PE ratio of -0.40, profit margin of 0.00%, and ROE of -2.26%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

PEG Ratio-0.00

Areas of Concern

ROE-2.26%
Operating Margin0.00%
Cash Position2.62%
Current Ratio0.15
We analyze MBAI's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -258.2/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-258.2/100

We analyze MBAI's fundamental strength across five key dimensions:

Efficiency Score

Weak

MBAI struggles to generate sufficient returns from assets.

ROA > 10%
-66.71%

Valuation Score

Excellent

MBAI trades at attractive valuation levels.

PE < 25
-0.40
PEG Ratio < 2
-0.00

Growth Score

Weak

MBAI faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

MBAI shows balanced financial health with some risks.

Debt/Equity < 1
-0.09
Current Ratio > 1
0.15

Profitability Score

Weak

MBAI struggles to sustain strong margins.

ROE > 15%
-226.19%
Net Margin ≥ 15%
0.00%
Positive Free Cash Flow
No

Key Financial Metrics

Is MBAI Expensive or Cheap?

P/E Ratio

MBAI trades at -0.40 times earnings. This suggests potential undervaluation.

-0.40

PEG Ratio

When adjusting for growth, MBAI's PEG of -0.00 indicates potential undervaluation.

-0.00

Price to Book

The market values Check-Cap Ltd. Ordinary Share at -6.94 times its book value. This may indicate undervaluation.

-6.94

EV/EBITDA

Enterprise value stands at -0.40 times EBITDA. This is generally considered low.

-0.40

How Well Does MBAI Make Money?

Net Profit Margin

For every $100 in sales, Check-Cap Ltd. Ordinary Share keeps $0.00 as profit after all expenses.

0.00%

Operating Margin

Core operations generate 0.00 in profit for every $100 in revenue, before interest and taxes.

0.00%

ROE

Management delivers $-2.26 in profit for every $100 of shareholder equity.

-2.26%

ROA

Check-Cap Ltd. Ordinary Share generates $-66.71 in profit for every $100 in assets, demonstrating efficient asset deployment.

-66.71%

Following the Money - Real Cash Generation

FCF Per Share

Each share generates $-1.37 in free cash annually.

$-1.37

FCF Yield

MBAI converts -78.17% of its market value into free cash.

-78.17%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.40

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.00

vs 25 benchmark

P/B Ratio

Price to book value ratio

-6.94

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.00

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-0.09

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.15

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-2.26

vs 25 benchmark

ROA

Return on assets percentage

-66.71

vs 25 benchmark

ROCE

Return on capital employed

18.10

vs 25 benchmark

How MBAI Stacks Against Its Sector Peers

MetricMBAI ValueSector AveragePerformance
P/E Ratio-0.4028.25 Better (Cheaper)
ROE-226.19%780.00% Weak
Net Margin0.00%-20122.00% (disorted) Weak
Debt/Equity-0.090.30 Strong (Low Leverage)
Current Ratio0.154.66 Weak Liquidity
ROA-6670.82%-14687.00% (disorted) Weak

MBAI outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Check-Cap Ltd. Ordinary Share's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ